Patents by Inventor TUGAN MUFTULER
TUGAN MUFTULER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250148285Abstract: Functional activation-based analysis of deep neural networks uses a structured set of inputs (e.g., input datasets corresponding to different knowledge or datatype domains) are sequentially provided to a pretrained neural network (e.g., according to a block-sequence). The output values for each node in the neural network are recorded and stored as a time-series of layer output values. A statistical analysis of the time-series of layer output values may be fit as a function of the structured set of inputs to generate neural network analysis data that indicate activations of layers within the neural network based on the inputs.Type: ApplicationFiled: November 4, 2024Publication date: May 8, 2025Inventors: Andrew Scott Nencka, Lutfi Tugan Muftuler, Peter LaViolette, Kevin Matthew Koch
-
Publication number: 20240415932Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.Type: ApplicationFiled: August 26, 2024Publication date: December 19, 2024Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
-
Patent number: 12168038Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.Type: GrantFiled: April 13, 2020Date of Patent: December 17, 2024Assignee: VENTURIS THERAPEUTICS, INC.Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
-
Patent number: 11540740Abstract: Systems and methods for designing and fabricating three-dimensional objects with precisely computed material compositions for use in enhancing electromagnetic fields for magnetic resonance imaging (“MRI”) are provided. As examples, the fabricated object can be designed to reduce magnetic field inhomogeneities in the main magnetic field of an MRI system, or to reduce inhomogeneities in a transmit radio frequency (“RF”) field (i.e., a B1 field). As examples, the object can be a shim; a housing or other part of an RF coil; a medical device, such as a surgical implant; or component used in a medical device, such as a housing for an implantable medical device.Type: GrantFiled: May 20, 2015Date of Patent: January 3, 2023Assignee: The Medical College of Wisconsin, Inc.Inventors: Andrew S. Nencka, Andrzej Jesmanowicz, James S. Hyde, Eric S. Paulson, Lutfi Tugan Muftuler, Daniel Shefchik
-
Patent number: 11224635Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.Type: GrantFiled: March 15, 2013Date of Patent: January 18, 2022Assignees: Venturis Thereuptics, Inc.Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
-
Publication number: 20200237873Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.Type: ApplicationFiled: April 13, 2020Publication date: July 30, 2020Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
-
Patent number: 10712418Abstract: Systems and methods for performing diffusion-weighted multi-spectral imaging (“MS!”) with a magnetic resonance imaging (“MRI”) system are provided, Diffusion-weighted images can thus be acquired from a subject in which a metallic object, such as an implant or other device, is present. In general, a two-dimensional or three-dimensional diffusion-weighted PROPELLER acquisition is performed to acquire data from multiple different spectral bins. Images from the spectral bins are reconstructed and combined to form diffusion-weighted composite images. Non-CPMG phase-cycling and split-blade PROPELLER techniques are combined with PROPELLER MSI metal artifact mitigation principles to this end.Type: GrantFiled: May 13, 2016Date of Patent: July 14, 2020Assignee: The Medical College of Wisconsin, Inc.Inventors: Kevin M. Koch, Lutfi Tugan Muftuler
-
Patent number: 10624952Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.Type: GrantFiled: December 17, 2014Date of Patent: April 21, 2020Assignees: CardioVascular BioTherapeutics, Inc.Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
-
Publication number: 20180136297Abstract: Systems and methods for performing diffusion-weighted multi-spectral imaging (“MS!”) with a magnetic resonance imaging (“MRI”) system are provided, Diffusion-weighted images can thus be acquired from a subject in which a metallic object, such as an implant or other device, is present. In general, a two-dimensional or three-dimensional diffusion-weighted PROPELLER acquisition is performed to acquire data from multiple different spectral bins. Images from the spectral bins are reconstructed and combined to form diffusion-weighted composite images. Non-CPMG phase-cycling and split-blade PROPELLER techniques are combined with PROPELLER MSI metal artifact mitigation principles to this end.Type: ApplicationFiled: May 13, 2016Publication date: May 17, 2018Inventors: Kevin M. Koch, Lutfi Tugan Muftuler
-
Patent number: 9880247Abstract: A method for highly accelerated projection imaging (“HAPI”) is provided. In this method, conventional linear gradients are used to obtain coil sensitivity-weighted projections of the object being imaged. Only a relatively small number of projections, such as sixteen or less, of the object are required to reconstruct a two-dimensional image of the object, unlike conventional projection imaging techniques. The relationship between the voxel values of the imaged object and the coil sensitivity-weighted projections is formulated as a linear system of equations and the reconstructed images are obtained by solving this matrix equation. This method advantageously allows higher acceleration rates compared to echo planar imaging (“EPI”) with SENSE or GRAPPA acceleration. Moreover, the method does not require any additional or specialized hardware because hardware in conventional MRI scanners is adequate to implement the method.Type: GrantFiled: May 31, 2013Date of Patent: January 30, 2018Assignee: The Medical College of WisconsinInventors: Lutfi Tugan Muftuler, Ali Ersoz, Volkan Emre Arpinar
-
Publication number: 20150164994Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.Type: ApplicationFiled: December 17, 2014Publication date: June 18, 2015Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
-
Publication number: 20150137811Abstract: A method for highly accelerated projection imaging (“HAPI”) is provided. In this method, conventional linear gradients are used to obtain coil sensitivity-weighted projections of the object being imaged. Only a relatively small number of projections, such as sixteen or less, of the object are required to reconstruct a two-dimensional image of the object, unlike conventional projection imaging techniques. The relationship between the voxel values of the imaged object and the coil sensitivity-weighted projections is formulated as a linear system of equations and the reconstructed images are obtained by solving this matrix equation. This method advantageously allows higher acceleration rates compared to echo planar imaging (“EPI”) with SENSE or GRAPPA acceleration. Moreover, the method does not require any additional or specialized hardware because hardware in conventional MRI scanners is adequate to implement the method.Type: ApplicationFiled: May 31, 2013Publication date: May 21, 2015Inventors: Lutfi Tugan Muftuler, Ali Ersoz, Volkan Emre Arpinar
-
Patent number: 8983570Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.Type: GrantFiled: March 24, 2008Date of Patent: March 17, 2015Assignee: Cardiovascular Biotherapeutics, Inc.Inventors: Thomas J. Stegmann, Kenneth A. Thomas, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Hon Yu, Vance Gardner
-
Publication number: 20130230454Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.Type: ApplicationFiled: March 15, 2013Publication date: September 5, 2013Applicant: CARDIOVASCULAR BIOTHERAPEUTICS, INC.Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
-
Publication number: 20090076481Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.Type: ApplicationFiled: March 24, 2008Publication date: March 19, 2009Inventors: THOMAS J. STEGMANN, KENNETH A. THOMAS, JOHN W. JACOBS, TUGAN MUFTULER, SHADFAR BAHRI, HON YU, VANCE GARDNER